カテゴリー： Market Monitor Global, 世界, 医療/バイオ

低分子CDMOの世界市場見通し2023年-2029年

◆英語タイトル：Small Molecule CDMO Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23FB2223）

◆商品コード：MMG23FB2223
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年2月
◆ページ数：118
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の低分子CDMO市場規模と予測を収録しています。・世界の低分子CDMO市場：売上、2018年-2023年、2024年-2029年
・世界の低分子CDMO市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の低分子CDMO市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「開発」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

低分子CDMOのグローバル主要企業は、Lonza、Catalent、Thermo Fisher、Wuxi Apptec、PharmaBlock、Asym Chemical、Jiuzhou Pharmaceutical、Pharmaron Beijing、Porton Pharma、ChemPartner、Jiangsu Sinopep、DELPHARM、Aenova Group、Siegfried Holding AG、Recipharm AB、FAREVA SA、Almac Group、Cambrex、Charles River、CORDEN PHARMA、Jubilant Pharmova、Consort Medicalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、低分子CDMOのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の低分子CDMO市場：タイプ別、2018年-2023年、2024年-2029年
世界の低分子CDMO市場：タイプ別市場シェア、2022年
・開発、原薬製造

世界の低分子CDMO市場：用途別、2018年-2023年、2024年-2029年
世界の低分子CDMO市場：用途別市場シェア、2022年
・医薬品、バイオ医薬品

世界の低分子CDMO市場：地域・国別、2018年-2023年、2024年-2029年
世界の低分子CDMO市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における低分子CDMOのグローバル売上、2018年-2023年
・主要企業における低分子CDMOのグローバル売上シェア、2022年
・主要企業における低分子CDMOのグローバル販売量、2018年-2023年
・主要企業における低分子CDMOのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Lonza、Catalent、Thermo Fisher、Wuxi Apptec、PharmaBlock、Asym Chemical、Jiuzhou Pharmaceutical、Pharmaron Beijing、Porton Pharma、ChemPartner、Jiangsu Sinopep、DELPHARM、Aenova Group、Siegfried Holding AG、Recipharm AB、FAREVA SA、Almac Group、Cambrex、Charles River、CORDEN PHARMA、Jubilant Pharmova、Consort Medical

*************************************************************

・調査・分析レポートの概要
低分子CDMO市場の定義
市場セグメント
世界の低分子CDMO市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の低分子CDMO市場規模
世界の低分子CDMO市場規模：2022年 VS 2029年
世界の低分子CDMO市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの低分子CDMOの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の低分子CDMO製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：開発、原薬製造
低分子CDMOのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：医薬品、バイオ医薬品
低分子CDMOの用途別グローバル売上・予測

・地域別市場分析
地域別低分子CDMO市場規模 2022年と2029年
地域別低分子CDMO売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Lonza、Catalent、Thermo Fisher、Wuxi Apptec、PharmaBlock、Asym Chemical、Jiuzhou Pharmaceutical、Pharmaron Beijing、Porton Pharma、ChemPartner、Jiangsu Sinopep、DELPHARM、Aenova Group、Siegfried Holding AG、Recipharm AB、FAREVA SA、Almac Group、Cambrex、Charles River、CORDEN PHARMA、Jubilant Pharmova、Consort Medical
...

This report aims to provide a comprehensive presentation of the global market for Small Molecule CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule CDMO. This report contains market size and forecasts of Small Molecule CDMO in global, including the following market information:
Global Small Molecule CDMO Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Small Molecule CDMO market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Development Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Small Molecule CDMO include Lonza, Catalent, Thermo Fisher, Wuxi Apptec, PharmaBlock, Asym Chemical, Jiuzhou Pharmaceutical, Pharmaron Beijing and Porton Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Small Molecule CDMO companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
[Total Market by Segment]
Global Small Molecule CDMO Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Small Molecule CDMO Market Segment Percentages, by Type, 2022 (%)
Development
API Production
Global Small Molecule CDMO Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Small Molecule CDMO Market Segment Percentages, by Application, 2022 (%)
Pharmaceutical
Biopharmaceutical
Global Small Molecule CDMO Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Small Molecule CDMO Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Small Molecule CDMO revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Small Molecule CDMO revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lonza
Catalent
Thermo Fisher
Wuxi Apptec
PharmaBlock
Asym Chemical
Jiuzhou Pharmaceutical
Pharmaron Beijing
Porton Pharma
ChemPartner
Jiangsu Sinopep
DELPHARM
Aenova Group
Siegfried Holding AG
Recipharm AB
FAREVA SA
Almac Group
Cambrex
Charles River
CORDEN PHARMA
Jubilant Pharmova
Consort Medical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Small Molecule CDMO, market overview.
Chapter 2: Global Small Molecule CDMO market size in revenue.
Chapter 3: Detailed analysis of Small Molecule CDMO company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Small Molecule CDMO in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Small Molecule CDMO Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Small Molecule CDMO Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Small Molecule CDMO Overall Market Size
2.1 Global Small Molecule CDMO Market Size: 2022 VS 2029
2.2 Global Small Molecule CDMO Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Small Molecule CDMO Players in Global Market
3.2 Top Global Small Molecule CDMO Companies Ranked by Revenue
3.3 Global Small Molecule CDMO Revenue by Companies
3.4 Top 3 and Top 5 Small Molecule CDMO Companies in Global Market, by Revenue in 2022
3.5 Global Companies Small Molecule CDMO Product Type
3.6 Tier 1, Tier 2 and Tier 3 Small Molecule CDMO Players in Global Market
3.6.1 List of Global Tier 1 Small Molecule CDMO Companies
3.6.2 List of Global Tier 2 and Tier 3 Small Molecule CDMO Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Small Molecule CDMO Market Size Markets, 2022 & 2029
4.1.2 Development
4.1.3 API Production
4.2 By Type – Global Small Molecule CDMO Revenue & Forecasts
4.2.1 By Type – Global Small Molecule CDMO Revenue, 2018-2023
4.2.2 By Type – Global Small Molecule CDMO Revenue, 2024-2029
4.2.3 By Type – Global Small Molecule CDMO Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Small Molecule CDMO Market Size, 2022 & 2029
5.1.2 Pharmaceutical
5.1.3 Biopharmaceutical
5.2 By Application – Global Small Molecule CDMO Revenue & Forecasts
5.2.1 By Application – Global Small Molecule CDMO Revenue, 2018-2023
5.2.2 By Application – Global Small Molecule CDMO Revenue, 2024-2029
5.2.3 By Application – Global Small Molecule CDMO Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Small Molecule CDMO Market Size, 2022 & 2029
6.2 By Region – Global Small Molecule CDMO Revenue & Forecasts
6.2.1 By Region – Global Small Molecule CDMO Revenue, 2018-2023
6.2.2 By Region – Global Small Molecule CDMO Revenue, 2024-2029
6.2.3 By Region – Global Small Molecule CDMO Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Small Molecule CDMO Revenue, 2018-2029
6.3.2 US Small Molecule CDMO Market Size, 2018-2029
6.3.3 Canada Small Molecule CDMO Market Size, 2018-2029
6.3.4 Mexico Small Molecule CDMO Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Small Molecule CDMO Revenue, 2018-2029
6.4.2 Germany Small Molecule CDMO Market Size, 2018-2029
6.4.3 France Small Molecule CDMO Market Size, 2018-2029
6.4.4 U.K. Small Molecule CDMO Market Size, 2018-2029
6.4.5 Italy Small Molecule CDMO Market Size, 2018-2029
6.4.6 Russia Small Molecule CDMO Market Size, 2018-2029
6.4.7 Nordic Countries Small Molecule CDMO Market Size, 2018-2029
6.4.8 Benelux Small Molecule CDMO Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Small Molecule CDMO Revenue, 2018-2029
6.5.2 China Small Molecule CDMO Market Size, 2018-2029
6.5.3 Japan Small Molecule CDMO Market Size, 2018-2029
6.5.4 South Korea Small Molecule CDMO Market Size, 2018-2029
6.5.5 Southeast Asia Small Molecule CDMO Market Size, 2018-2029
6.5.6 India Small Molecule CDMO Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Small Molecule CDMO Revenue, 2018-2029
6.6.2 Brazil Small Molecule CDMO Market Size, 2018-2029
6.6.3 Argentina Small Molecule CDMO Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Small Molecule CDMO Revenue, 2018-2029
6.7.2 Turkey Small Molecule CDMO Market Size, 2018-2029
6.7.3 Israel Small Molecule CDMO Market Size, 2018-2029
6.7.4 Saudi Arabia Small Molecule CDMO Market Size, 2018-2029
6.7.5 UAE Small Molecule CDMO Market Size, 2018-2029
7 Small Molecule CDMO Companies Profiles
7.1 Lonza
7.1.1 Lonza Company Summary
7.1.2 Lonza Business Overview
7.1.3 Lonza Small Molecule CDMO Major Product Offerings
7.1.4 Lonza Small Molecule CDMO Revenue in Global Market (2018-2023)
7.1.5 Lonza Key News & Latest Developments
7.2 Catalent
7.2.1 Catalent Company Summary
7.2.2 Catalent Business Overview
7.2.3 Catalent Small Molecule CDMO Major Product Offerings
7.2.4 Catalent Small Molecule CDMO Revenue in Global Market (2018-2023)
7.2.5 Catalent Key News & Latest Developments
7.3 Thermo Fisher
7.3.1 Thermo Fisher Company Summary
7.3.2 Thermo Fisher Business Overview
7.3.3 Thermo Fisher Small Molecule CDMO Major Product Offerings
7.3.4 Thermo Fisher Small Molecule CDMO Revenue in Global Market (2018-2023)
7.3.5 Thermo Fisher Key News & Latest Developments
7.4 Wuxi Apptec
7.4.1 Wuxi Apptec Company Summary
7.4.2 Wuxi Apptec Business Overview
7.4.3 Wuxi Apptec Small Molecule CDMO Major Product Offerings
7.4.4 Wuxi Apptec Small Molecule CDMO Revenue in Global Market (2018-2023)
7.4.5 Wuxi Apptec Key News & Latest Developments
7.5 PharmaBlock
7.5.1 PharmaBlock Company Summary
7.5.2 PharmaBlock Business Overview
7.5.3 PharmaBlock Small Molecule CDMO Major Product Offerings
7.5.4 PharmaBlock Small Molecule CDMO Revenue in Global Market (2018-2023)
7.5.5 PharmaBlock Key News & Latest Developments
7.6 Asym Chemical
7.6.1 Asym Chemical Company Summary
7.6.2 Asym Chemical Business Overview
7.6.3 Asym Chemical Small Molecule CDMO Major Product Offerings
7.6.4 Asym Chemical Small Molecule CDMO Revenue in Global Market (2018-2023)
7.6.5 Asym Chemical Key News & Latest Developments
7.7 Jiuzhou Pharmaceutical
7.7.1 Jiuzhou Pharmaceutical Company Summary
7.7.2 Jiuzhou Pharmaceutical Business Overview
7.7.3 Jiuzhou Pharmaceutical Small Molecule CDMO Major Product Offerings
7.7.4 Jiuzhou Pharmaceutical Small Molecule CDMO Revenue in Global Market (2018-2023)
7.7.5 Jiuzhou Pharmaceutical Key News & Latest Developments
7.8 Pharmaron Beijing
7.8.1 Pharmaron Beijing Company Summary
7.8.2 Pharmaron Beijing Business Overview
7.8.3 Pharmaron Beijing Small Molecule CDMO Major Product Offerings
7.8.4 Pharmaron Beijing Small Molecule CDMO Revenue in Global Market (2018-2023)
7.8.5 Pharmaron Beijing Key News & Latest Developments
7.9 Porton Pharma
7.9.1 Porton Pharma Company Summary
7.9.2 Porton Pharma Business Overview
7.9.3 Porton Pharma Small Molecule CDMO Major Product Offerings
7.9.4 Porton Pharma Small Molecule CDMO Revenue in Global Market (2018-2023)
7.9.5 Porton Pharma Key News & Latest Developments
7.10 ChemPartner
7.10.1 ChemPartner Company Summary
7.10.2 ChemPartner Business Overview
7.10.3 ChemPartner Small Molecule CDMO Major Product Offerings
7.10.4 ChemPartner Small Molecule CDMO Revenue in Global Market (2018-2023)
7.10.5 ChemPartner Key News & Latest Developments
7.11 Jiangsu Sinopep
7.11.1 Jiangsu Sinopep Company Summary
7.11.2 Jiangsu Sinopep Business Overview
7.11.3 Jiangsu Sinopep Small Molecule CDMO Major Product Offerings
7.11.4 Jiangsu Sinopep Small Molecule CDMO Revenue in Global Market (2018-2023)
7.11.5 Jiangsu Sinopep Key News & Latest Developments
7.12 DELPHARM
7.12.1 DELPHARM Company Summary
7.12.2 DELPHARM Business Overview
7.12.3 DELPHARM Small Molecule CDMO Major Product Offerings
7.12.4 DELPHARM Small Molecule CDMO Revenue in Global Market (2018-2023)
7.12.5 DELPHARM Key News & Latest Developments
7.13 Aenova Group
7.13.1 Aenova Group Company Summary
7.13.2 Aenova Group Business Overview
7.13.3 Aenova Group Small Molecule CDMO Major Product Offerings
7.13.4 Aenova Group Small Molecule CDMO Revenue in Global Market (2018-2023)
7.13.5 Aenova Group Key News & Latest Developments
7.14 Siegfried Holding AG
7.14.1 Siegfried Holding AG Company Summary
7.14.2 Siegfried Holding AG Business Overview
7.14.3 Siegfried Holding AG Small Molecule CDMO Major Product Offerings
7.14.4 Siegfried Holding AG Small Molecule CDMO Revenue in Global Market (2018-2023)
7.14.5 Siegfried Holding AG Key News & Latest Developments
7.15 Recipharm AB
7.15.1 Recipharm AB Company Summary
7.15.2 Recipharm AB Business Overview
7.15.3 Recipharm AB Small Molecule CDMO Major Product Offerings
7.15.4 Recipharm AB Small Molecule CDMO Revenue in Global Market (2018-2023)
7.15.5 Recipharm AB Key News & Latest Developments
7.16 FAREVA SA
7.16.1 FAREVA SA Company Summary
7.16.2 FAREVA SA Business Overview
7.16.3 FAREVA SA Small Molecule CDMO Major Product Offerings
7.16.4 FAREVA SA Small Molecule CDMO Revenue in Global Market (2018-2023)
7.16.5 FAREVA SA Key News & Latest Developments
7.17 Almac Group
7.17.1 Almac Group Company Summary
7.17.2 Almac Group Business Overview
7.17.3 Almac Group Small Molecule CDMO Major Product Offerings
7.17.4 Almac Group Small Molecule CDMO Revenue in Global Market (2018-2023)
7.17.5 Almac Group Key News & Latest Developments
7.18 Cambrex
7.18.1 Cambrex Company Summary
7.18.2 Cambrex Business Overview
7.18.3 Cambrex Small Molecule CDMO Major Product Offerings
7.18.4 Cambrex Small Molecule CDMO Revenue in Global Market (2018-2023)
7.18.5 Cambrex Key News & Latest Developments
7.19 Charles River
7.19.1 Charles River Company Summary
7.19.2 Charles River Business Overview
7.19.3 Charles River Small Molecule CDMO Major Product Offerings
7.19.4 Charles River Small Molecule CDMO Revenue in Global Market (2018-2023)
7.19.5 Charles River Key News & Latest Developments
7.20 CORDEN PHARMA
7.20.1 CORDEN PHARMA Company Summary
7.20.2 CORDEN PHARMA Business Overview
7.20.3 CORDEN PHARMA Small Molecule CDMO Major Product Offerings
7.20.4 CORDEN PHARMA Small Molecule CDMO Revenue in Global Market (2018-2023)
7.20.5 CORDEN PHARMA Key News & Latest Developments
7.21 Jubilant Pharmova
7.21.1 Jubilant Pharmova Company Summary
7.21.2 Jubilant Pharmova Business Overview
7.21.3 Jubilant Pharmova Small Molecule CDMO Major Product Offerings
7.21.4 Jubilant Pharmova Small Molecule CDMO Revenue in Global Market (2018-2023)
7.21.5 Jubilant Pharmova Key News & Latest Developments
7.22 Consort Medical
7.22.1 Consort Medical Company Summary
7.22.2 Consort Medical Business Overview
7.22.3 Consort Medical Small Molecule CDMO Major Product Offerings
7.22.4 Consort Medical Small Molecule CDMO Revenue in Global Market (2018-2023)
7.22.5 Consort Medical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 低分子CDMOの世界市場見通し2023年-2029年(Small Molecule CDMO Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

低分子CDMOの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp